Expression of Oncostatin M in Early Gastric Cancer and Precancerous Lesions

Table 3

Expression of OSM in different types of gastric mucosal lesions.

	()	and ()	()	Pearson’s chi-squared test
Gastritis ()^a,b,c,d,e	27 (41.5%)	38 (58.5%)	0 (0%)
IM ()^f,g,h	3 (6.7%)	41 (91.1%)	1 (2.2%)
LGIN ()^i,j	3 (13.6%)	16 (72.7%)	3 (13.6%)
HGIN ()^k	0 (0%)	28 (60.9%)	18 (39.1%)
EGC ()	2 (6.1%)	16 (48.5%)	15 (45.5%)
AGC ()	3 (17.6%)	11 (64.7%)	3 (17.6%)

^aChi-squared test, , significant difference compared with intestinal metaplasia (IM); ^bchi-squared test, , significant difference compared with LGIN; ^cchi-squared test, , significant difference compared with HGIN; ^dchi-squared test, , significant difference compared with EGC; ^echi-squared test, , significant difference compared with AGC; ^fchi-squared test, , significant differences compared with HGIN and EGC; ^gchi-squared test, , significant difference compared with EGC; ^hchi-squared test, , significant difference compared with AGC; ⁱchi-squared test, , significant difference compared with HGIN; ^jchi-squared test, , significant difference compared with EGC; ^kchi-squared test, , significant difference compared with AGC.